Thursday, February 2, 2023

CDC updates vaccine recommendation for immunocompromised individuals

The Centers for Disease Control and Prevention have changed their Covid-19 vaccine recommendations for people who are moderately to severely immunocompromised. 

Recent data shows booster doses should be given to the immunocompromised at least three months following their third dose. The CDC previously recommended waiting at least five months after the third dose was administered.

The CDC now recommends three initial doses, as well as a booster dose at least three months following the third dose. This applies to the immunocompromised, 12 years or older, who have received the Pfizer-BioNTech vaccine, and those 18 and older who have received the Moderna vaccine.

All immunocompromised people who are 18 and older and have received a single Johnson & Johnson shot should receive two followup doses: a second of an mRNA vaccine (Pfizer or Moderna), and a booster dose following at least two months after the second shot. 

New recommendations apply to individuals at least 12 years of age. Booster doses have not been made available for ages 5-11. Only the Pfizer vaccine is available to immunocompromised children 5-17 as an additional dose.

Recent CDC updates can be found here.

Have tips or comments? Email

Shea Carver
Shea Carver
Shea Carver is the editor in chief at Port City Daily. A UNCW alumna, Shea worked in the print media business in Wilmington for 22 years before joining the PCD team in October 2020. She specializes in arts coverage — music, film, literature, theatre — the dining scene, and can often be tapped on where to go, what to do and who to see in Wilmington. When she isn’t hanging with her pup, Shadow Wolf, tending the garden or spinning vinyl, she’s attending concerts and live theater.

Related Articles